| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |